Inclusion of more-specific leukocyte subtypes, including regulatory T cells (a subset of CD4+ T cells) that are often found in the tumor microenvironment,75 may provide additional insights into the interplay of the immune system and breast cancer risk. This evidence concerns the gene CD4 and neoplasm.